End-of-day quote
Other stock markets
|
||
- GBX | - |
12:34pm | GSK : DZ Bank remains Neutral | ZD |
11:17am | GSK plc : Back on track |
Sales 2024 * | 31.58B 39.64B | Sales 2025 * | 33.51B 42.06B | Capitalization | 70.49B 88.48B |
---|---|---|---|---|---|
Net income 2024 * | 5.59B 7.01B | Net income 2025 * | 6.47B 8.13B | EV / Sales 2024 * | 2.62 x |
Net Debt 2024 * | 12.32B 15.46B | Net Debt 2025 * | 9.13B 11.46B | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
12.7
x | P/E ratio 2025 * |
10.9
x | Employees | - |
Yield 2024 * |
3.53% | Yield 2025 * |
3.66% | Free-Float | 94.38% |
Latest transcript on GlaxoSmithKline plc
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Urs Rohner
BRD | Director/Board Member | 65 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 681B | |
+19.74% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.24% | 235B | |
+4.34% | 199B | |
-11.86% | 189B | |
-3.79% | 157B |